Feminizing hormone therapy

Feminizing hormone therapy, also known as transfeminine hormone therapy, is hormone therapy and sex reassignment therapy to change the secondary sex characteristics of transgender people from masculine or androgynous to feminine. It is a common type of transgender hormone therapy (another being masculinizing hormone therapy) and is used to treat transgender women and non-binary transfeminine individuals. Some, in particular intersex people, but also some non-transgender people, take this form of therapy according to their personal needs and preferences.

Transgender topics
Part of a series on

Outline History Timeline
Gender identities Androgyne Bissu, Calabai, Calalai Burrnesha Cisgender Gender bender Hijra Non-binary or genderqueer Gender fluidity Kathoey Koekchuch Third gender Bakla Faʻafafine Femminiello Khanith Māhū Mudoko dako Mukhannath Muxe Travesti Two-spirit Winkte X-gender Trans man Trans woman Fakaleitī Mak nyah Rae-rae Transgender Youth Akava'ine Transsexual
Health care practices Gender clinic Gender dysphoria in children Sex assignment Hormone therapy feminizing masculinizing Puberty-suppressing hormone therapy Gender-affirming surgery female-to-male male-to-female Facial feminization surgery Facial masculinization surgery Hair removal Pregnancy Assisted reproductive technology Voice therapy WPATH Standards of Care
Rights and legal status Gender self-identification Legal gender Non-binary gender Rights movement Organizations Asylum Healthcare Military service South Korea United States Prisons Toilets Bathroom bills Unisex Anti-gender movement Discrimination Non-binary Parental rights movement Transgender men Transmisogyny Genocide Inequality Violence Murders Trans panic defense Yogyakarta Principles
Society and culture Events and awareness Awareness Week Beauty pageants Day of Remembrance Day of Visibility Flag March more Culture Fictional characters Film Literature Media portrayals People Non-binary Publications Religion Sports Television
Theory and concepts Androphilia and gynephilia Blanchard's typology Childhood gender nonconformity Cisgender / cissexual Cisnormativity Cross-dressing Deadnaming Gender binary Gender detransitioning Gender expression Gender transitioning Gender identity Gender-sexuality questioning Gender variance Postgenderism Rapid-onset dysphoria Studies Transfeminism views Transmedicalism Transmisogyny
By country Rights Argentina 2012 law 2021 law Australia Brazil Canada 2016 bill China Finland France Germany India 2014 bill 2019 act Tamil Nadu Iran Ireland Pakistan 2017 bill 2018 act New Zealand Norway 2016 act Singapore South Africa 2003 act South Korea Spain 2022 law United Kingdom 2004 act United States Disenfranchisement Title IX Transphobia History Argentina Australia Re Kevin Brazil China Finland Nazi Germany Singapore United Kingdom United States Legality Cafeteria riot Stonewall
See also Gender Gender studies Intersex Queer heterosexuality LGBT Sex Sex–gender distinction Sexual orientation Social construction of gender
Transgender portal LGBT portal Category

The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired sex, such as breasts and a feminine pattern of hair, fat, and muscle distribution. It cannot undo many of the changes produced by naturally occurring puberty, which may necessitate surgery and other treatments to reverse (see below). The medications used for feminizing hormone therapy include estrogens, antiandrogens, progestogens, and gonadotropin-releasing hormone modulators (GnRH modulators).

Feminizing hormone therapy has been empirically shown to reduce the distress and discomfort associated with gender dysphoria in transfeminine individuals.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.